In Deal Worth $330 Million, The Drugmaker, Takeda Acquires PvP Biologics Company
Posted by
www.biotecnika.org
Takeda Acquires PvP Biologics Takeda, the Japanese pharma company has
exercised its option to acquire the San Diego-based PvP Biologics
company for $330 million three years after both the companies inked a
$35 million deal to develop a novel treatment for celiac disease.
After the Phase I trial conclusion for TAK-062, also known as Kuma062
[…]
The post In Deal Worth $330 Million, The Drugmaker, Takeda Acquires
PvP Biologics Company appeared first on Rasayanika .
https://www.rasayanika.com/2020/03/04/takeda-acquires-pvp-biologics-in-deal-worth-330-million/
News
Subscribe to:
Post Comments (Atom)
Post a Comment